About Client: Our client’s vision is to integrate ESG and climate considerations into every business decision to drive sustainable growth. By utilising the latest data, AI, and technology, they aim to help organisations accelerate their ti...
. About the Role As a Senior Banking Consultant in our Retail Banking, you'll play a key role in helping to deliver the desired... Consultant, you will have the opportunity to: Act as ANZ products initiator and role model, Eagerly support the Branch...
Results-Driven Sales Consultant Are you motivated by success and eager to achieve exceptional results? Do you thrive... Sales Consultant, you'll leverage your sales expertise to promote award-winning personal development products and leadership...
In this role, you will source candidates, cultivate client relationships, and excel in a collaborative team setting. Your strong sales orientation will fuel growth, ensuring the business remains profitable and sustainable. Client Details ...
Chile, home to the world’s biggest lithium reserves, is confident that investors will compete for licenses to drill new deposits even amid a worsening global glut that’s squeezing the battery-metal industry. Continue Reading »
Gold Prices Today: Gold of 99.9 and 99.5 per cent purity grew ₹2,320 each in the last seven trading sessions. However, silver prices declined ₹500 to ₹93,500 per kg from the previous close Continue Reading »
At 11:57 a.m. ET, the Dow Jones Industrial Average rose 0.58 per cent, the S&P 500 gained 0.14 per cent, the Nasdaq Composite lost 0.19 per cent Continue Reading »
Expert view: Mohit Khanna anticipates the Union Budget 2025 will prioritize youth, women, the poor, and farmers, with increased spending on rural housing, irrigation, and employment-linked incentives. Continue Reading »
HPCL Q3 Results: The state-owned OMC's revenue from operations in the third quarter of current fiscal rose to ₹1.10 lakh crore led by better marketing margins. Continue Reading »
Dr Reddy's Laboratories reported a 2% YoY increase in PAT to ₹1,413.3 crore for Q3 2024, driven by a 16% rise in revenue to ₹8,358.6 crore. The company invested ₹6.7 billion in R&D, focusing on complex generics and biosimilars. Continue Reading »